Diabetic conditions act as matchmaker for monocytes and vascular smooth muscle cells.
Authors:
- 1 March 2010
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 298 (3) , H731-3
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Diabetic conditions promote binding of monocytes to vascular smooth muscle cells and their subsequent differentiationAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Role of Smooth Muscle Cells in the Initiation and Early Progression of AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- High glucose conditions induce upregulation of fractalkine and monocyte chemotactic protein-1 in human smooth muscle cellsThrombosis and Haemostasis, 2008
- Enhanced Proatherogenic Responses in Macrophages and Vascular Smooth Muscle Cells Derived From Diabetic db/db MiceDiabetes, 2006
- Interaction of Monocytes With Vascular Smooth Muscle Cells Regulates Monocyte Survival and Differentiation Through Distinct PathwaysArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Lipid Inflammatory Mediators in Diabetic Vascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Inflammation in atherosclerosisNature, 2002
- Biochemistry and molecular cell biology of diabetic complicationsNature, 2001
- CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolismJournal of Clinical Investigation, 2001
- A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994